----

| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---|-----------------------------------------------------------------------------------------|

|  ̈ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|--------|------------------------------------------------------------------------------------------|

----

----

| Delaware                                                       |   | 22-3542636                           |
|----------------------------------------------------------------|--------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization) |   | (I.R.S. Employer Identification No.) |

| 165 Ludlow Avenue, Northvale, New Jersey |   | 07647      |
|------------------------------------------|--------|------------|
| (Address of principal executive offices) |   | (Zip Code) |

----

| Large Accelerated filer   ̈ | Accelerated Filer   ̈ | Non-Accelerated Filer   ̈ |  Smaller Reporting Company  x |
|-------------------------------------------|-------------------------------------|-----------------------------------------|----------------------------------------------|

----

----

| ExhibitNumber |   | Description                                                                                                                                                                                                                                                                                                      |
|---------------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 10.5          |   | Asset Purchase Agreement, dated as of August 27, 2010, by and among Mikah Pharma LLC and the Company.   A description of this Asset Purchase Agreement is incorporated by reference to Item 2.01 of the Current Report on Form 8-K, dated August 27, 2010 and filed with SEC on September 1, 2010 |
|          |   |                                                                                                                                                                                                                                                                                                             |
| 31.1          |   | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                                                                                                                                                                                               |
|          |   |                                                                                                                                                                                                                                                                                                             |
| 31.2          |   | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                                                                                                                                                                                               |
|          |   |                                                                                                                                                                                                                                                                                                             |
| 32.1          |   | Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002                                                                                                                                                                                                               |
|          |   |                                                                                                                                                                                                                                                                                                             |
| 32.2          |   | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002                                                                                                                                                                                                               |

----

|                                                                                                                                         |   | ELITE PHARMACEUTICALS, INC.                  |
|----------------------------------------------------------------------------------------------------------------------------------------------|--------|----------------------------------------------|
|                                                                                                                                         |   |                                         |
| Date:       April 26, 2011               |   | /s/ Jerry Treppel                            |
|                                                                                                                                         |   | Jerry Treppel                                |
|                                                                                                                                         |   | Chief Executive Officer                      |
|                                                                                                                                         |   | (Principal Executive Officer)                |
|                                                                                                                                         |   |                                         |
| Date:      April 26, 2011                     |   | /s/ Carter J. Ward                           |
|                                                                                                                                         |   | Carter J. Ward                               |
|                                                                                                                                         |   | Chief Financial Officer                      |
|                                                                                                                                         |   | (Principal Financial and Accounting Officer) |

----